These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 33580861)

  • 1. Oxidative stress in phenylketonuria-evidence from human studies and animal models, and possible implications for redox signaling.
    Bortoluzzi VT; Dutra Filho CS; Wannmacher CMD
    Metab Brain Dis; 2021 Apr; 36(4):523-543. PubMed ID: 33580861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creatine plus pyruvate supplementation prevents oxidative stress and phosphotransfer network disturbances in the brain of rats subjected to chemically-induced phenylketonuria.
    Bortoluzzi VT; Brust L; Preissler T; de Franceschi ID; Wannmacher CMD
    Metab Brain Dis; 2019 Dec; 34(6):1649-1660. PubMed ID: 31352540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress induced by phenylketonuria in the rat: Prevention by melatonin, vitamin E, and vitamin C.
    Martinez-Cruz F; Pozo D; Osuna C; Espinar A; Marchante C; Guerrero JM
    J Neurosci Res; 2002 Aug; 69(4):550-8. PubMed ID: 12210848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant treatment strategies for hyperphenylalaninemia.
    Mazzola PN; Karikas GA; Schulpis KH; Dutra-Filho CS
    Metab Brain Dis; 2013 Dec; 28(4):541-50. PubMed ID: 23657560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress in phenylketonuria: what is the evidence?
    Ribas GS; Sitta A; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2011 Jul; 31(5):653-62. PubMed ID: 21516352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress in phenylketonuria: future directions.
    Rocha JC; Martins MJ
    J Inherit Metab Dis; 2012 May; 35(3):381-98. PubMed ID: 22116469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights from Animal Models on the Pathophysiology of Hyperphenylalaninemia: Role of Mitochondrial Dysfunction, Oxidative Stress and Inflammation.
    Wyse ATS; Dos Santos TM; Seminotti B; Leipnitz G
    Mol Neurobiol; 2021 Jun; 58(6):2897-2909. PubMed ID: 33550493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetrahydrobiopterin treatment in phenylketonuria: A repurposing approach.
    Evers RAF; van Vliet D; van Spronsen FJ
    J Inherit Metab Dis; 2020 Mar; 43(2):189-199. PubMed ID: 31373030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of catalase and superoxide dismutase activities on oxidative stress in the brain of a phenylketonuria animal model and the effect of lipoic acid.
    Moraes TB; Jacques CE; Rosa AP; Dalazen GR; Terra M; Coelho JG; Dutra-Filho CS
    Cell Mol Neurobiol; 2013 Mar; 33(2):253-60. PubMed ID: 23232760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress in a phenylketonuria animal model.
    Ercal N; Aykin-Burns N; Gurer-Orhan H; McDonald JD
    Free Radic Biol Med; 2002 May; 32(9):906-11. PubMed ID: 11978492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of oxidative stress parameters in treated phenylketonuric patients.
    Sitta A; Barschak AG; Deon M; Terroso T; Pires R; Giugliani R; Dutra-Filho CS; Wajner M; Vargas CR
    Metab Brain Dis; 2006 Dec; 21(4):287-96. PubMed ID: 17146735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal serum phenylalanine for adult patients with phenylketonuria.
    Okano Y; Nagasaka H
    Mol Genet Metab; 2013 Dec; 110(4):424-30. PubMed ID: 24094552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients.
    Sitta A; Vanzin CS; Biancini GB; Manfredini V; de Oliveira AB; Wayhs CA; Ribas GO; Giugliani L; Schwartz IV; Bohrer D; Garcia SC; Wajner M; Vargas CR
    Cell Mol Neurobiol; 2011 Apr; 31(3):429-36. PubMed ID: 21191647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoic acid prevents oxidative stress in vitro and in vivo by an acute hyperphenylalaninemia chemically-induced in rat brain.
    Moraes TB; Zanin F; da Rosa A; de Oliveira A; Coelho J; Petrillo F; Wajner M; Dutra-Filho CS
    J Neurol Sci; 2010 May; 292(1-2):89-95. PubMed ID: 20226470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOX, the main regulator in oxidative stress in experimental models of phenylketonuria?
    He Y; Gu X; Lu L; Liang L; Gao J; Zhang X
    J Pediatr Endocrinol Metab; 2013; 26(7-8):675-82. PubMed ID: 23612646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newly validated biomarkers of brain damage may shed light into the role of oxidative stress in the pathophysiology of neurocognitive impairment in dietary restricted phenylketonuria patients.
    Rausell D; García-Blanco A; Correcher P; Vitoria I; Vento M; Cháfer-Pericás C
    Pediatr Res; 2019 Jan; 85(2):242-250. PubMed ID: 30333522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coenzyme Q10 in phenylketonuria and mevalonic aciduria.
    Hargreaves IP
    Mitochondrion; 2007 Jun; 7 Suppl():S175-80. PubMed ID: 17442628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studying the effect of large neutral amino acid supplements on oxidative stress in phenylketonuric patients.
    Kumru B; Ozturk Hismi B; Kaplan DS; Celik H
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):269-274. PubMed ID: 30835252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Future treatment strategies in phenylketonuria.
    van Spronsen FJ; Enns GM
    Mol Genet Metab; 2010; 99 Suppl 1():S90-5. PubMed ID: 20123478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Of mice and men: Plasma phenylalanine reduction in PKU corrects neurotransmitter pathways in the brain.
    Berguig GY; Martin NT; Creer AY; Xie L; Zhang L; Murphy R; Pacheco G; Bullens S; Olbertz J; Weng HH
    Mol Genet Metab; 2019 Dec; 128(4):422-430. PubMed ID: 31648944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.